TANG CAPITAL PARTNERS LP 13D/13G Filings for Heron Therapeutics, Inc. (HRTX)

TANG CAPITAL PARTNERS LP 13D and 13G filings for Heron Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-14
4:00 pm
Sale		 2022-12-31 13G Heron Therapeutics, Inc.
HRTX		 TANG CAPITAL PARTNERS LP 3,756,694
3.200%		 -4,026,994decrease
(-51.74%)		 Filing
2022-02-14
4:00 pm
Purchase		 2021-12-31 13G Heron Therapeutics, Inc.
HRTX		 TANG CAPITAL PARTNERS LP 7,783,688
7.600%		 144,588increase
(+1.89%)		 Filing
2021-02-16
4:15 pm
Sale		 2020-12-31 13G Heron Therapeutics, Inc.
HRTX		 TANG CAPITAL PARTNERS LP 7,639,100
7.800%		 -2,110,244decrease
(-21.64%)		 Filing
2020-11-19
4:00 pm
Purchase		 2008-10-14 13G Heron Therapeutics, Inc.
HRTX		 TANG CAPITAL PARTNERS LP 9,749,344
9.990%		 169,415increase
(+1.77%)		 Filing